SCHEMBL4694359

SCHEMBL4694359

Cc1ccc(N(CCCN2CC3=CN(C(=O)c4c(C)ccnc4C)CC3C2)C(=O)Nc2ccc(Cl)cc2Cl)cc1Cl

nearest known ligand 0.34

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 14/20 0.34
USP30 Q70CQ3 1/20 0.34
KCNH2 Q12809 1/20 0.34
UBE2M P61081 1/20 0.33
DCUN1D1 Q96GG9 1/20 0.33
POLB P06746 1/20 0.33
CACNA1G O43497 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4694867 0.92 CCR5 (0.34) CCR5KCNH2
SCHEMBL4690445 0.92 EPHX2 (0.38) CCR5KCNH2
SCHEMBL4691722 0.90 CCR5 (0.39) CCR5USP30KCNH2UBE2MDCUN1D1
SCHEMBL4690611 0.89 CCR5 (0.37) CCR5KCNH2UBE2MDCUN1D1
SCHEMBL4694952 0.89 CCR5 (0.37) CCR5KCNH2UBE2MDCUN1D1
SCHEMBL4691638 0.88 CCR5 (0.37) CCR5KCNH2
SCHEMBL4694148 0.88 MAPT (0.36) CCR5KCNH2UBE2MDCUN1D1
SCHEMBL4691621 0.88 CCR5 (0.35) CCR5KCNH2
SCHEMBL4690740 0.88 CCR5 (0.42) CCR5KCNH2
SCHEMBL4694419 0.87 CCR5 (0.36) CCR5KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1761542-B1 OCTAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AN THEIR USE AS ANTIVIRAL AGENTS HOFFMANN LA ROCHE (CH) 2008-01-02 EP claimed
EP-1761542-A2 OCTAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AN THEIR USE AS ANTIVIRAL AGENTS F.HOFFMANN-LA ROCHE AG (CH) 2007-03-14 EP claimed
WO-2005121145-A2 OCTAHYDRO-PYRROLO[3,4-C] DERIVATIVES AND THEIR USE AS ANTIVIRAL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2005-12-22 WO claimed
EP-1761542-B1 OCTAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AN THEIR USE AS ANTIVIRAL AGENTS HOFFMANN LA ROCHE (CH) 2008-01-02 EP disclosed